Opportunity Radar

← Back to search

Grant

Immune Tolerance Network (UM1 Clinical Trial Required)

View on Grants.gov ↗ Sign in to save

Type
Grant
Notice type
CA
Agency
National Institutes of Health
Sub-agency
HHS-NIH11
Solicitation #
RFA-AI-28-005
Posted
Oct 20, 2026
Response due
Jan 29, 2027
Archive date
Mar 29, 2027
CFDA / Assistance listing
93.855
Total program funding
$27,000,000
Contact
ITN_UM1@mail.nih.gov
Source
Grants.gov

Description

The purpose of this notice of funding opportunity (NOFO) is to support applications to continue the Immune Tolerance Network (ITN). The primary objective of the Network is to develop tolerogenic therapies for immune-mediated disorders. The three main clinical areas of work are: 1) Allergic diseases and asthma; 2) Autoimmune diseases; and 3) Immune-mediated consequences of transplantation. The core functions of the ITN include designing, conducting, and sharing the results of clinical trials and performing integrated mechanistic studies.

Similar open opportunities